Take a look at the session abstracts, workshop focus & categories, plus the instruction level below, then click here to register!

Saturday, August 23, 2014
1:00 PM - 2:30 PM WS# 17: How to Bring New Antibodies into Your Clinical IHC Laboratory
Presented by: Debra Horton, MT(ASCP)QIHC, Technical Specialist at University Hospital in Birmingham, AL

You just had a Pathologist come to you and want to bring in a new antibody to be used in the clinical laboratory. Now what? What steps are necessary to make this an easy transaction from your Pathologist request to a validated antibody in your laboratory. What are CAP requirements necessary to bring a antibody in your laboratory? Is the antibody a RUO, ASR, or IVD and do you even know what that means? Is the antibody compatible to the reagents you are already using in your lab? Let's take this one step at a time. We will take an example of an antibody request and move it through the process from beginning to end. We will make sure we have all the documentation and testing done to meet all CAP requirements. We will setup a process that is easy to follow when a request for new antibodies are needed, making this easy for you and making the Pathologist happy.

Workshop Focus: Clinical
Workshop Category: Immunohistochemistry
Instruction Level: Basic
3:00 PM - 4:30 PM WS# 27: Validations: What IHC Means to Me
Presented by: Erin Grimes, HT(ASCP) Mayo Clinic, Scottsdale, AZ

Validation and optimization of assays, antibodies and equipment contribute significantly to high-quality patient care and also increase laboratory performance measures. Without accurate, well-documented validations, test results may not be accurate or reliable. The College of American Pathologists (CAP) and other accrediting agencies have regulatory requirements for validation protocols and associated documentation. In this educational session, the validation and optimization processes will be detailed in straightforward steps to ensure consistency, accuracy and manageability of these integral components of laboratory operations. A focus on validation of immunohistochemistry assays will be highlighted for histology lab personnel.

Workshop Focus: Clinical
Workshop Categories: Immunohistocehemistry & Regulations
Instruction Level: Intermediate
Monday, August 25, 2014
8:00 AM - 9:30 AM WS# 75: Surgical Pathology Dissection; A Histotech’s Guide to Grossing
Presented by: Dale Telgenhoff, PhD, HTL(ASCP)CM, Associate Professor at Tarleton State University, Ft. Worth, TX

The gross room is where specimens are accessioned into the histology laboratory, and the role of the histotechnician in this process is critical for the macroscopic analysis of tissues. Traditionally the work involved accessioning specimens into the LIS system, cassette preparation, ordering specimens, stocking, and clean-up. More and more these roles are expanding, with some hospitals employing histotechnologists for the gross analysis and preparation of specimens for histology. This workshop will review the fundamentals of gross dissection such as orientation, dissection, marking, description, and sampling. We will also examine the role of the pathologist, pathology assistant, and histotechnologist in this evolving area of the laboratory. Safety concerns in the gross room will be discussed, as well as requisitions, considerations for different tissue types, and the purpose of a slide index.

Workshop Focus: Clinical
Workshop Category: Techniques & Fundamentals
Instruction Level: Intermediate
Tuesday, August 26, 2014
8:00 AM - 9:30 AM WS# 91: Breast Cancer: Gross and Microscopic Pathology, Biology, Immunohistochemistry and Molecular Diagnosis
Presented by: Thomas Haas, D.O., Pathologist at Mercy Health Systems, Inc., Janesville, WI

Breast cancer is one of the more common diseases of the 21st century, affecting thousands of women (and men) every year, and is a leading cause of cancer mortality in the United States and throughout the world. This seminar will explore both traditional light-microscopic morphology of the 19th and 20th centuries, as well as the IHC-based classifications of breast cancer (Luminal A and B, Basal and HER2 forms)first laid out in the early 21st century. An in-depth discussion of other IHC stains and panels useful in the diagnosis of breast cancer and confirmation of the various subtypes will be included. New diagnostic methods such as gene signatures and molecular markers will be explored and discussed, as well as standard therapies and those now being developed. The seminar will also look at risk factors for breast cancer, premalignant lesions, heredity/family genetics, and other important information about breast disease, beginning with a quick overview of cancer principles and how these various factors can influence the risk for breast cancer.

Workshop Focus: Clinical
Workshop Categories: Immunohistochemistry & Molecular
Instruction Level: Advanced

Questions? Email Jessica or call the NSH Office, 443.535.4060.

You are connected to the secure server. You are connected to the secure server.
Registration Powered By eShow